anti-NA mAbs (Abzyme Therapeutics)

N/A

Report date: 2025/03/18 18:06:25

Base Information

Drug Nameanti-NA mAbs (Abzyme Therapeutics)
Drug Alias Nameanti-neuraminidase mAbs (Abzyme)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionNeuraminidase inhibitors
TargetsNeuraminidase
Therapy Area/IndicationsInfluenza A virus infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbzyme Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesAbzyme Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A